Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aurora Spine Corp V.ASG

Alternate Symbol(s):  ASAPF

Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, biologics, and Non-Fusion. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

New Press Release - Aurora Spine Corporation Issued Patent by USPTO For Its Interlaminar Single Implant Technology For Motion Preservation or Fusion

CARLSBAD, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of United States Patent No: 11...read article.

Wonderful news for Aurora Spine

This is great news for Aurora Spine.  Their DEXA-C cervical implant was rolled out in Q1 in a controlled rollout to 2 doctors.  The results from this DEXA-C Q1 slow rollout produced sales of...read more

New Press Release - Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumbar Interbody Fusion Device as part of its DEXA Technology Platform

CARLSBAD, Calif, June 06, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it had received FDA 510(k) clearance for...read article.

New SeekingAlpha writeup Aurora Spine

https://flipboard.com/@seekingalpha/long-ideas-qh6lsjv0z/aurora-spine-has-three-shots-on-goal/a-94ObBTjvRVyy3O4o3k0I5w%3Aa%3A138960686-85142fc60c%2Fseekingalpha.com?format=amp  rate and reply

Nice Quarter

With continued doctor training and a secondary DEXA-C rollout it's  possible Q2 will see sales break $4m.  If so I expect we will see profitability.  rate and reply

New Press Release - Aurora Spine Corporation Announces Record First Quarter Fiscal 2022 Financial Results

Company reports highest quarterly revenue in Company’s history of $3.55 million, 57% year over year increase and 20% sequential growth from Q4 - Management to host conference call today, May 24, 2022 at 11:00 AM ET - NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE...read article.

Aurora Spine Q1 earnings tomorrow morning

My guess is they announce sales of $3.45-3.5m.  Management let it out that they hit profitability in Q1 on an SCD call.  They also stated that Silo has grown sales from $1m for all of last...read more

New Press Release - Aurora Spine Corporation Schedules Release for First Quarter Fiscal Year 2022 Financial Results and Conference Call

CARLSBAD, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it will issue its financial results press...read article.

ASG.V Aurora Spine is moving counter trend to the market

Aurora is moving counter trend to the market.  It's looking ready to break out.  There's no longer much left on the ask. To top it off Aurora should announce positive cash flow for...read more

SCD interview Aurora Spine

Great introduction to Aurora Spine for those who don't know the story.   https://m.youtube.com/watch?v=nC3Y_cdLQw8&feature=youtu.be At some point the value guys will take notice and...read more

Aurora Spine zoom call Wednesday May 11th at 8 am pacific

For anyone interested in taking part in an Aurora Spine Zoom call with CEO Trent Northcutt this Wednesday May 11th, send me a DM and I will include you on the call.    rate and reply

Q1 earnings will be out before the end of May

Aurora's Q1 2022 earnings will be sequentially higher than Q4 2021's which were the second best results in company history.  We have been informed that expenses will be lower than what we...read more

From conference call

-Aurora has grown from having 40 doctors selling Aurora's pain division product/devices to now 60 as of the call.        -Aurora is training another 300 doctors this...read more

$2.96M USD Q4 2021 with Q1 2022 to be sequentially higher

Sales are growing as a result of more spinal pain clinics offering Aurora's devices.  Management continues to train doctors on their Zip and Silo devices and plan to train 400 in total for...read more

Aurora spine webcast Lytham Partners

This call gave a different perspective from the doctors point of view.  https://wsw.com/webcast/lytham4/register.aspx?conf=lytham4&page=asg.v&url=https://wsw.com/webcast/lytham4/asg.v...read more

RE:RE:RE:The spinal device sector’s M&A is alive and well.

Spine surgery innovator Accelus to launch IPO via SPAC https://capital.com/spine-surgery-innovator-accelus-to-launch-ipo-via-spac  rate and reply

RE:RE:The spinal device sector’s M&A is alive and well.

Globus Medical eyes acquisition of spinal implant maker NuVasive-sources   https://www.reuters.com/business/healthcare-pharmaceuticals/global-medical-eyes-acquisition-spinal-implant-maker...read more

RE:The spinal device sector’s M&A is alive and well.

That didn't post well.  Let's try that again.   The spinal device sector's top 5 players make up 80% of industry sales.  The smaller industry players are the innovators...read more

The spinal device sector’s M&A is alive and well.

The spinal device sector@s top 5 players make up 80% of industry sales. The smaller industry players are the innovators who develop new tech and end up being acquired by the top 5. The 6 most high...read more

The spinal device sector’s M&A is alive and well.

The spinal device sector's top 5 players make up 80% of industry sales. The smaller industry players are the innovators who develop new tech and end up being acquired by the top 5. The 6 most high...read more